what glp 1 does serena williams take and the coming reckoning with GLP-1s and performance enhancement Serena Williams Opens Up About

Firstly, subcutaneous semaglutide has already been proven to be superior to placebo in reducing cardiovascular risk, while the data on oral semaglutides cardiovascular benefits wont be available until 2024

Unlimited 24/7 support included

Prasad, F

Foundayo, another oral GLP-1 option available, provides flexibility in dosing

doi: 10.1016/j.drudis.2016.01.016 66 GimenoD.KivimakiM.BrunnerE

People who have severe gastrointestinal conditions like inflammatory bowel disease (IBD) or gastroparesis should not go on GLP-1s, and neither should people with a personal or family history of multiple endocrine neoplasia 2A, multiple endocrine neoplasia 2B, medullary thyroid cancer, or pancreatitis